| Metric | Q3 2026 | Q3 2025 |
|---|---|---|
| Revenue | 823.0 | 783.0 |
| Profit before tax | 160.0 | 146.0 |
| Net income | 108.0 | 100.0 |
| EPS (diluted, $ a share) | $0.53 | $0.49 |
A dash means the filing did not report that period. Growth is not shown when either period was a loss. Figures from the filing's XBRL data.
| Net income, year on year | +8.0% |
|---|---|
| Revenue, year on year | +5.1% |
| Operating margin | 19.7% |
10-Q filed with the SEC, NYSE: ULS. Figures from the filing's XBRL data; summary written with AI assistance from the filing.
UL Solutions Inc.: key numbers
- Share price
- $78.13Close, Nov 16
- Sector
- Industrial Applications and Services
- Industry
- Services-Testing LaboratoriesSIC 8734
Today's reference numbers, updated daily. Not a valuation or a recommendation.
More from UL Solutions Inc.
All →UL Solutions Signs $350M M&A Deal with Worldly Holdings Inc.
UL Solutions Inc. has entered into a definitive agreement to acquire Worldly Holdings Inc., a supply chain intelligence software company, for an aggregate consideration of $350 million. The deal will be funded through a mix of cash, revolving credit, and approximately $127 million in Class A common stock. To offset the dilution from the stock issuance, UL Solutions also agreed to repurchase $130 million of its Class B common stock from its majority shareholder, UL Standards & Engagement.
- Value
- $350M
- Counterparty
- Worldly Holdings Inc.
“This acquisition will build on our supply chain intelligence capabilities and our expanding role in digital trust, helping customers gain greater visibility into where and how their products are made.”
Jennifer Scanlon, President and CEO
UL Solutions President and CEO Jennifer F. Scanlon Sells $938K of Stock
Jennifer F. Scanlon, President and CEO, sold 12,500 shares of UL Solutions Inc. at $74.81 to $75.83 a share (average $75.03) in 2 transactions, worth $938K in total on Nov 2, 2026. Shares held after the trade: 114,224 (-2.3%).
- Value
- $938K
- Shares
- 12,500
- Average price
- $75.03
- Role
- President and CEO
- Holding change
- -2.3%
- Trade date
- Nov 2, 2026
UL Solutions Financial Results
UL Solutions reported third-quarter 2026 revenue of $823 million, representing 5.1% total growth and 7.0% organic growth driven by the Industrial and Consumer segments. Net income rose 10.4% to $117 million, while Adjusted EBITDA margin expanded 90 basis points to a record 28.6%. Based on strong performance, the company raised its full-year organic revenue growth outlook to approximately 6.5%.
- Term
- Q3 2026
“This quarter’s record revenue and excellent margin expansion reflect our strategic focus and investments aligned to the megatrends including the global energy transition and electrification of everything. We are at the forefront of innovation and work alongside our customers as increasingly digital, interconnected products and supply chains drive demand for our trusted services and software.”
Jennifer Scanlon, President and CEO
“Our third-quarter results reflect continued strong execution across the business. We achieved 7.0% organic revenue growth and expanded our Adjusted EBITDA margin to a record 28.6%, driven by broad-based demand, operating leverage and productivity gains.”
Ryan Robinson, Executive Vice President and Chief Financial Officer
UL Solutions President and CEO Jennifer F. Scanlon Sells $876K of Stock
Jennifer F. Scanlon, President and CEO, sold 12,500 shares of UL Solutions Inc. at $70.08 a share, worth $876K in total on Oct 8, 2026. Shares held after the trade: 126,724 (-9.0%).
- Value
- $876K
- Shares
- 12,500
- Price
- $70.08
- Role
- President and CEO
- Holding change
- -9.0%
- Trade date
- Oct 8, 2026
UL Solutions M&A Deal with Eurofins Scientific SE
UL Solutions Inc. has completed the acquisition of the electrical and electronics (E&E) business of Eurofins Scientific SE. The deal expands UL Solutions' global footprint and testing, inspection, and certification (TIC) capabilities across EMEA, Asia, and the United States, specifically in electromagnetic compatibility, wireless testing, and medical devices.
- Counterparty
- Eurofins Scientific SE